Literature DB >> 16352426

The power of the pump: mechanisms of action of P-glycoprotein (ABCB1).

Suresh V Ambudkar1, In-Wha Kim, Zuben E Sauna.   

Abstract

Members of the superfamily of ATP-binding cassette (ABC) transporters mediate the movement of a variety of substrates including simple ions, complex lipids and xenobiotics. At least 18 ABC transport proteins are associated with disease conditions. P-glycoprotein (Pgp, ABCB1) is the archetypical mammalian ABC transport protein and its mechanism of action has received considerable attention. There is strong biochemical evidence that Pgp moves molecular cargo against a concentration gradient using the energy of ATP hydrolysis. However, the molecular details of how the energy of ATP hydrolysis is coupled to transport remain in dispute and it has not been possible to reconcile the data from various laboratories into a single model. The functional unit of Pgp consists of two nucleotide binding domains (NBDs) and two trans-membrane domains which are involved in the transport of drug substrates. Considerable progress has been made in recent years in characterizing these functionally and spatially distinct domains of Pgp. In addition, our understanding of the domains has been augmented by the resolution of structures of several non-mammalian ABC proteins. This review considers: (i) the role of specific conserved amino acids in ATP hydrolysis mediated by Pgp; (ii) emerging insights into the dimensions of the drug binding pocket and the interactions between Pgp and the transport substrates and (iii) our current understanding of the mechanisms of coupling between energy derived from ATP binding and/or hydrolysis and efflux of drug substrates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16352426     DOI: 10.1016/j.ejps.2005.10.010

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  60 in total

1.  Conformational analysis of human ATP-binding cassette transporter ABCB1 in lipid nanodiscs and inhibition by the antibodies MRK16 and UIC2.

Authors:  Tasha K Ritchie; Hyewon Kwon; William M Atkins
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

2.  Identification of a putatively multixenobiotic resistance related Abcb1 transporter in amphipod species endemic to the highly pristine Lake Baikal.

Authors:  Vasiliy V Pavlichenko; Marina V Protopopova; Maxim Timofeyev; Till Luckenbach
Journal:  Environ Sci Pollut Res Int       Date:  2014-11-05       Impact factor: 4.223

3.  Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.

Authors:  Christopher A Elkins; Lisa B Mullis
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

Review 4.  Molecular basis of the polyspecificity of P-glycoprotein (ABCB1): recent biochemical and structural studies.

Authors:  Eduardo E Chufan; Hong-May Sim; Suresh V Ambudkar
Journal:  Adv Cancer Res       Date:  2015-01-08       Impact factor: 6.242

Review 5.  On a biophysical and mathematical model of Pgp-mediated multidrug resistance: understanding the "space-time" dimension of MDR.

Authors:  Vasiliki Panagiotopoulou; Giles Richardson; Oliver E Jensen; Cyril Rauch
Journal:  Eur Biophys J       Date:  2009-11-04       Impact factor: 1.733

6.  Global alteration of the drug-binding pocket of human P-glycoprotein (ABCB1) by substitution of fifteen conserved residues reveals a negative correlation between substrate size and transport efficiency.

Authors:  Shahrooz Vahedi; Eduardo E Chufan; Suresh V Ambudkar
Journal:  Biochem Pharmacol       Date:  2017-07-17       Impact factor: 5.858

7.  Design, synthesis, and biological evaluation of (S)-valine thiazole-derived cyclic and noncyclic peptidomimetic oligomers as modulators of human P-glycoprotein (ABCB1).

Authors:  Satyakam Singh; Nagarajan Rajendra Prasad; Khyati Kapoor; Eduardo E Chufan; Bhargav A Patel; Suresh V Ambudkar; Tanaji T Talele
Journal:  Chembiochem       Date:  2013-11-29       Impact factor: 3.164

8.  Synthesis and Characterization of Bodipy-FL-Cyclosporine A as a Substrate for Multidrug Resistance-Linked P-Glycoprotein (ABCB1).

Authors:  Andaleeb Sajid; Natarajan Raju; Sabrina Lusvarghi; Shahrooz Vahedi; Rolf E Swenson; Suresh V Ambudkar
Journal:  Drug Metab Dispos       Date:  2019-08-01       Impact factor: 3.922

Review 9.  Nanovehicular intracellular delivery systems.

Authors:  Ales Prokop; Jeffrey M Davidson
Journal:  J Pharm Sci       Date:  2008-09       Impact factor: 3.534

10.  Substrate-dependent breast cancer resistance protein (Bcrp1/Abcg2)-mediated interactions: consideration of multiple binding sites in in vitro assay design.

Authors:  Nagdeep Giri; Sagar Agarwal; Naveed Shaik; Guoyu Pan; Ying Chen; William F Elmquist
Journal:  Drug Metab Dispos       Date:  2008-12-04       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.